Crescita Therapeutics Inc financial statements, including revenue, expenses, profit, and loss
The total revenue of CRRTF for the last quarter is 3.57 M USD, and it's 59.68% higher compared to the previous quarter. The net income of Q4 23 is -113.17 k USD.